Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-Center, Open Label Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease
Brief Summary: The purpose of this study is to determine the efficacy of chitosan chewing gum (K2CG) in reducing serum phosphorus in subjects with chronic kidney disease.


Options:
A: Arm Label: 900 mg Phosphate Diet-LC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lanthanum Carbonate, Other: 900 mg Phosphate Diet | Arm Label: Ad Libitum Diet-LC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lanthanum Carbonate, Other: Ad Libitum Diet | Arm Label: 900 mg Phosphate Diet-LC Placebo; Type: ACTIVE_COMPARATOR; Interventions: Other: 900 mg Phosphate Diet, Drug: LC Placebo | Arm Label: Ad Libitum Diet-LC Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: LC Placebo, Other: Ad Libitum Diet | Intervention Type: DRUG; Name: Lanthanum Carbonate; Assigned to Arm(s): 900 mg Phosphate Diet-LC, Ad Libitum Diet-LC | Intervention Type: OTHER; Name: 900 mg Phosphate Diet; Assigned to Arm(s): 900 mg Phosphate Diet-LC, 900 mg Phosphate Diet-LC Placebo | Intervention Type: DRUG; Name: LC Placebo; Assigned to Arm(s): 900 mg Phosphate Diet-LC Placebo, Ad Libitum Diet-LC Placebo | Intervention Type: OTHER; Name: Ad Libitum Diet; Assigned to Arm(s): Ad Libitum Diet-LC, Ad Libitum Diet-LC Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Niacinamide | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Niacinamide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: ESRD: FOSTRAP Chewing Gum; Type: ACTIVE_COMPARATOR; Interventions: Other: FOSTRAP Chewing Gum | Arm Label: CKD: FOSTRAP Chewing Gum; Type: ACTIVE_COMPARATOR; Interventions: Other: FOSTRAP Chewing Gum | Arm Label: ESRD Matching Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo chewing gum | Arm Label: CKD Matching Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo chewing gum | Intervention Type: OTHER; Name: FOSTRAP Chewing Gum; Assigned to Arm(s): ESRD: FOSTRAP Chewing Gum | Intervention Type: OTHER; Name: FOSTRAP Chewing Gum; Assigned to Arm(s): ESRD: FOSTRAP Chewing Gum | Intervention Type: OTHER; Name: FOSTRAP Chewing Gum; Assigned to Arm(s): CKD: FOSTRAP Chewing Gum | Intervention Type: OTHER; Name: FOSTRAP Chewing Gum; Assigned to Arm(s): ESRD: FOSTRAP Chewing Gum | Intervention Type: OTHER; Name: Placebo chewing gum; Assigned to Arm(s): CKD Matching Placebo, ESRD Matching Placebo
D: Arm Label: K2CG chewing gum (20 mg chitosan); Type: ACTIVE_COMPARATOR; Interventions: Other: K2CG chewing gum (20mg chitosan) | Arm Label: K2CG chewing gum (60 mg chitosan); Type: ACTIVE_COMPARATOR; Interventions: Other: K2CG chewing gum (60mg chitosan) | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: K2CG chewing gum (20mg chitosan); Assigned to Arm(s): K2CG chewing gum (20 mg chitosan) | Intervention Type: OTHER; Name: K2CG chewing gum (60mg chitosan); Assigned to Arm(s): K2CG chewing gum (60 mg chitosan)

Answer: D